IncellDx, Inc. Signs Exclusive License With Claremont BioSolutions To Commercialize Novel Liquid-Based Biopsy Technology

MENLO PARK, Calif.--(BUSINESS WIRE)--IncellDx, Inc. announced today the signing of a worldwide, exclusive license and supply agreement with Claremont BioSolutions (Upland, CA) to couple their enzyme-free tissue homogenization technology with IncellDx’s patented reagents. The combination forms a sample preparation system called IncellPrep™ Liquid Biopsy, to prepare “universal” cell suspensions formed from either fresh or FFPE tissue. The IncellPrep Liquid Biopsy can be used with IncellDx reagents for multiplex detection of protein, mRNA, and DNA in intact cells by flow or image cytometry.

Help employers find you! Check out all the jobs and post your resume.